Muramatsu, Daisuke
Okabe, Mitsuyasu
Takaoka, Akinori
Kida, Hiroshi
Iwai, Atsushi
Article History
Received: 22 September 2016
Accepted: 24 April 2017
First Online: 6 June 2017
Competing Interests
: There is a potential competing interest. This study was funded by Aureo Co., Ltd., Kimitsu, Japan, and Aureo-Science Co., Ltd., Sapporo, Japan. However, the funding sources had no role in the study design, data collection, or analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. D.M. and A.I. are employees of Aureo-Science Co., Ltd., and M.O. and A.I. are employees of Aureo Co., Ltd. The AP-PG-containing <i>A</i>. <i>pullulans</i>-cultured fluid and its derivatives are marketed by Aureo Co., Ltd., and by Aureo-Science Co., Ltd. The results presented in this manuscript are patent pending in Japan (application number: 2016–135811), and the β-glucan-containing <i>Aureobasidium pullulans</i>-cultured fluid and its derivatives are marketed by Aureo-Science Co., Ltd., and by Aureo Co., Ltd. There are no other patents, products in development, or marketed products to declare.